XPeng L03 launches globally at the same time, with premium pricing in Europe potentially self-subsidizing its low-price strategy in China

Overview

This report focuses on the global launch of XPeng Inc.'s MONA L03. Morgan Stanley believes that L03 uses more aggressive pricing in China to defend share, while the simultaneous launch in Europe improves product mix and margins through higher pricing. The core judgment of the report is that investors should not look only at China ASP and margin pressure, because a rising share of European sales could make the overall profit contribution more accretive.

Core views

The core views include: first, L03's China pricing is below the pre-sale range and is paired with early-bird benefits, with the near-term goal of driving volume; second, the simultaneous European launch changes the pace of overseas expansion, which for most peers lags by about one year, allowing overseas high ASP and sales growth to arrive at the same time; third, if the supply chain and capacity ramp go smoothly, L03 monthly sales could exceed 15k; fourth, follow-up models G9L/L05 will further support the core automotive business; fifth, non-auto AI businesses such as VLA 2.0, Robotaxi, and humanoids could drive a valuation re-rating in 3Q.

Analysis framework

The report evaluates XPeng Inc. from five angles: product pricing, regional sales mix, capacity ramp-up, localized European operations, and non-auto AI businesses. The valuation section uses a probability-weighted DCF and references bull, base, and bear case weightings.

Methodology notes

• Valuation methodProbability-weighted DCF

  DCF and scenario weighting

  The target price is derived from the ADR target price using a 7.85 HKD/USD conversion, with 30%/50%/20% weights assigned to the bull, base, and bear cases, respectively.

• Key assumptionsMorgan Stanley ModelWare

  Model assumptions

  The base-case assumptions include a 3% terminal growth rate, 1.6x beta, and 12.8% WACC; the metrics in the report tables are based by default on the Morgan Stanley ModelWare framework.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• XPeng Inc. (9868.HK)

  Core covered name

  Strengths

  L03 pricing in China is competitive, and the simultaneous European launch brings higher ASP; asset-light localized production and channel deployment in Europe help address protectionism; the AI product line offers potential for valuation re-rating.

  Weaknesses

  Price cuts in China may pressure domestic ASP; supply ramp-up is the key constraint on translating sales potential into actual results; the company still faces pressure on profitability and cash flow.

  Comparison

  The report emphasizes that peers typically take about 18 months to gradually expand overseas, while XPeng Inc. launches simultaneously in China and Europe, meaning the contribution from higher overseas ASP is no longer delayed.

  Risks

  Intensifying competition in the mid-to-high-end market, profitability below expectations, cash flow pressure, and slower auto sales growth weighing on sector valuation.

Key data

• RatingOverweightMorgan Stanley maintains a relatively positive rating on XPeng Inc.
• Industry viewIn-LineThe covered industry is China Autos & Shared Mobility.
• Target priceHK$96.00The target price is converted from the ADR target price at 7.85 HKD/USD.
• Closing priceHK$56.55As of 2026-07-16.
• Implied upside70%Based on the target price and closing price disclosed in the report.
• China L03 BEV pricingRmb123.8-156.8kBelow the pre-sale price range of Rmb143.8-165.8k.
• China L03 PHEV pricingRmb123.8-146.8kThe PHEV version is expected to be available in August.
• Early-bird benefitsUp to Rmb43kUsed to strengthen early-stage demand after the China launch.
• Europe L03 pricingAbout Rmb276-299kBEV and EREV are about €35.6k and €38.6k respectively, clearly above China pricing.
• Monthly sales target view15k+On the condition that supply can ramp smoothly.

Impact & implications

The implication of the report is that the investment case for L03 is not just sales elasticity in the China market, but the combined improvement in revenue mix and gross margin once higher volume in China and higher pricing in Europe occur simultaneously. If L03, G9L, and L05 succeed in sequence, the core automotive business could gain more stable support; if commercialization expectations for VLA 2.0, Robotaxi, and humanoids rise, the market may assign XPeng Inc. a higher valuation multiple.

Risks

• Competition in the mid-to-high-end segment intensifies.
• Lower profitability puts pressure on cash flow.
• Slower auto sales growth suppresses overall industry valuation.
• A weak supply ramp could make the 15k+ monthly sales target difficult to achieve.
• If China's low-price strategy is not offset by higher ASP in Europe, overall margins could be compressed.

What to watch

• Whether L03 China orders, deliveries, and monthly sales run-rate break above 15k.
• The contribution of European L03 sales mix, ASP, and gross margin.
• The launch timing and demand performance of follow-up models G9L and L05.
• Progress in localized production in Graz, the 150-dealer network, and the European supply chain rollout.
• The timeline for VLA 2.0 launch in Europe, overseas Robotaxi partnerships, and commercialization of humanoids in stores and shopping malls.